Companies: 10,795·Total market cap: $144.5T
AIM ImmunoTech Inc.

AIM ImmunoTech Inc.

AIMAMEXHealthcare● Active
$0.52
+$0.00(+0.60%)
Market Cap$1766097
P/E Ratio
52W High$19.73812
52W Low$0.21
Overview

AIM ImmunoTech Inc. (AIM) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · AIM · as of Jun 8, 2026

Activity summary

Buy transactions

10

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

AIM ImmunoTech Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

AIM insider buying and selling by quarter

AIM insider selling · AIM insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
4.2M2.1M0
2025 Q1
2025 Q2
2025 Q3
2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · AIM ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

AIM executive sell shares · AIM board member insider trading · AIM insider trading SEC filing

Showing 59 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

CHEMEROW DAVID I.

Director

Other

Date

Mar 12

Shares

25,000

Price

Value

View Form 4 on SEC.gov

CHEMEROW DAVID I.

Director

Award

Date

Feb 5

Shares

2,800

Price

$1.23

Value

$3K

View Form 4 on SEC.gov

Equels Thomas K

CEO & President · Director

Purchase

Date

Jun 13

Shares

107

Price

$7.70

Value

$824

View Form 4 on SEC.gov

Equels Thomas K

CEO & President · Director

Purchase

Date

Jun 12

Shares

103

Price

$8.70

Value

$896

View Form 4 on SEC.gov

MITCHELL WILLIAM M

Director

Purchase

Date

Apr 11

Shares

196,851

Price

$0.03

Value

$5K

View Form 4 on SEC.gov

Equels Thomas K

CEO & President · Director

Purchase

Date

Apr 11

Shares

1,968,504

Price

$0.03

Value

$50K

View Form 4 on SEC.gov

KELLNER TED D

Director

Purchase

Date

Apr 11

Shares

1,968,504

Price

$0.03

Value

$50K

View Form 4 on SEC.gov

Equels Thomas K

CEO & President · Director

Purchase

Date

Apr 4

Shares

41,000

Price

$0.06

Value

$3K

View Form 4 on SEC.gov

Rodino Peter W III

COO, Secretary, Gen. Counsel

Purchase

Date

Apr 4

Shares

500

Price

$0.09

Value

$44

View Form 4 on SEC.gov

MITCHELL WILLIAM M

Director

Award

Date

Mar 14

Shares

44,899

Price

$0.12

Value

$5K

View Form 4 on SEC.gov

BRYAN NANCY

Director

Award

Date

Mar 14

Shares

44,899

Price

$0.12

Value

$5K

View Form 4 on SEC.gov

CHEMEROW DAVID I.

Director

Award

Date

Mar 14

Shares

44,899

Price

$0.12

Value

$5K

View Form 4 on SEC.gov

Equels Thomas K

CEO & President · Director

Purchase

Date

Mar 5

Shares

50,000

Price

$0.13

Value

$7K

View Form 4 on SEC.gov

Equels Thomas K

CEO & President · Director

Purchase

Date

Mar 4

Shares

44,000

Price

$0.12

Value

$5K

View Form 4 on SEC.gov

CHEMEROW DAVID I.

Director

Award

Date

Feb 28

Shares

19,290

Price

$0.14

Value

$3K

View Form 4 on SEC.gov

MITCHELL WILLIAM M

Director

Award

Date

Feb 28

Shares

38,580

Price

$0.14

Value

$5K

View Form 4 on SEC.gov

BRYAN NANCY

Director

Award

Date

Feb 28

Shares

38,580

Price

$0.14

Value

$5K

View Form 4 on SEC.gov

Equels Thomas K

CEO & President · Director

Purchase

Date

Mar 4

Shares

83,334

Price

$0.12

Value

$10K

View Form 4 on SEC.gov

MITCHELL WILLIAM M

Director

Award

Date

Feb 14

Shares

43,330

Price

$0.12

Value

$5K

View Form 4 on SEC.gov

BRYAN NANCY

Director

Award

Date

Feb 14

Shares

43,330

Price

$0.12

Value

$5K

View Form 4 on SEC.gov

MITCHELL WILLIAM M

Director

Award

Date

Jan 31

Shares

25,797

Price

$0.20

Value

$5K

View Form 4 on SEC.gov

BRYAN NANCY

Director

Award

Date

Jan 31

Shares

25,797

Price

$0.20

Value

$5K

View Form 4 on SEC.gov

Equels Thomas K

CEO & President · Director

Purchase

Date

Nov 21

Shares

20,000

Price

$0.21

Value

$4K

View Form 4 on SEC.gov

BRYAN NANCY

Director

Award

Date

Jan 15

Shares

27,412

Price

$0.19

Value

$5K

View Form 4 on SEC.gov

MITCHELL WILLIAM M

Director

Award

Date

Jan 15

Shares

27,412

Price

$0.19

Value

$5K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About AIM insider trading

AIM insider trades

AIM ImmunoTech Inc. (AIM) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including CHEMEROW DAVID I. (Director), Equels Thomas K (CEO & President · Director). Over the past 12 months, 2 insiders have filed transactions with the SEC. AIM insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For AIM ImmunoTech Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

AIM insider trading · 5 questions

The insiders of AIM ImmunoTech Inc. (AIM) include executives and directors such as CHEMEROW DAVID I. (Director), Equels Thomas K (CEO & President · Director), among others. Over the past 12 months, 2 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

AIM board member insider tradingwho are AIM insidersAIM insider rosterAIM ImmunoTech Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026